Obesity Clinical Trial
— SELFOfficial title:
Self-Efficacy in Weight Loss Treatment
| Verified date | July 2015 |
| Source | University of Pittsburgh |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
This randomized clinical trial of weight loss treatment will examine if adding personalized,
one-on-one treatment session to standard behavioral group treatment will result in greater
weight loss, less weight regain after weight loss, and better adherence to the treatment
protocol.
Everyone who enrolls in the study will receive information on healthy eating, how to
increase their physical activity and develop healthy exercise habits and ways to change
their eating so that they will lose weight. This information will be provided at evening
group sessions. There will be a total of 20 group meetings over an 18-month period that will
be held:
- every week during the first month of the study,
- every other week for the second month
- once a month for months 3-12
- every 6 weeks for months 13-18
Participants in the self-efficacy group will also be asked to participate in one-on-one
lifestyle counseling sessions with a study interventionist throughout the study.
Everyone will be asked to complete questionnaires, two 24-hour dietary recalls over the
phone, and have blood tests done every six months (at the beginning of the study, at 6, 12,
and 18 months) a total of 4 times for the study.
| Status | Completed |
| Enrollment | 120 |
| Est. completion date | April 2013 |
| Est. primary completion date | March 2013 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - age 18 years or older - BMI > 27 and < 43 - willing to be randomized to one of the two treatment conditions - successful completion of screening requiring 5-day recording of food intake in a paper diary - have at least two risk factors for coronary heart disease, e.g., overweight or obese, hypertension, dyslipidemia, positive family history (first degree relative) NOTE: Although residing in Western Pennsylvania is not an explicit eligibility criterion, participants are asked to travel to the University of Pittsburgh frequently (weekly for the first month) Exclusion Criteria: - presence of a current serious illness or unstable condition requiring physician-supervised diet and exercise (e.g., diabetes, recent acute myocardial infarction) for which physician supervision of diet and physical activity prescription is needed - physical limitations precluding ability to engage in physical activity at moderate intensity - pregnancy or intention to become pregnant in the next 18 months - current treatment for a psychological disorder - reported alcohol intake > 4 drinks/day - previous participation in a formal weight loss program within the past 5 years, e.g., Weight Watchers or a research program, or current use of weight loss medication - planned extended vacations, absences, or relocation within the next 18 months |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Pittsburgh School of Nursing | Pittsburgh | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| Lora Burke |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Weight | 12 and 18 months post enrollment | No | |
| Secondary | Health-related quality of life | 12 and 18 months post enrollment | No | |
| Secondary | Adherence to treatment protocol | 12 and 18 months post enrollment | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |